当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第2期
编号:13248075
黛力新联合替普瑞酮对慢性胃炎患者临床疗效及焦虑抑郁情绪的影响(4)
http://www.100md.com 2018年1月15日 《中国现代医生》 2018年第2期
     [15]Vagelj DE,Terzi V,Dovhanj J,et al. Superoxide dismutases in chronic gastritis[J]. APMIS,2016,124(4):252-256.

    [16]Chia JK,Chia AY,Wang D,et al. Functional dyspepsia and chronic gastritis associated with enteroviruses[J]. Open Journal of Gastroenterology,2015,5(4):21-27.

    [17]Soma N. Diagnosis of helicobacter pylori-related chronic gastritis,gastric adenoma and early gastric cancer by magnifying endoscopy[J]. J Dig Dis,2016,17(10):641-651.

    [18]Hashash JG,Abdul-Baki H,Azar C,et al. Clinical trial: A randomized controlled cross-over study of flupenthixol+melitracen in functional dyspepsia[J]. Aliment Pharmacol Ther,2008,27(11):1148-1155.

    [19]趙丽萍,王峰,杨晓丽. 氟哌噻吨美利曲辛联合替普瑞酮治疗伴有焦虑抑郁状态的慢性胃炎患者的疗效观察[J]. 内蒙古医学杂志,2014,(10):1220-1222.

    [20]廖国建. 氟哌噻吨美利曲辛片联合质子泵抑制剂对上腹痛综合征的疗效及对睡眠、心理状态影响[J]. 临床消化病杂志,2015,(4):209-212.

    [21]Yan XJ,Li WT,Chen X,et al. Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients[J]. World J Gastroenterol,2015,21(15):4652-4659.

    (收稿日期:2017-08-21), 百拇医药(吕雪幼 叶国良 邵永富)
上一页1 2 3 4